pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

7,405 catalysts · 3,350 8k filing · 1,080 grant · 1,000 device adverse event · 579 earnings · 519 approval · 408 device 510k

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-08-10: 0 catalysts2026-08-11: 0 catalysts2026-08-12: 0 catalysts2026-08-13: 0 catalysts2026-08-14: 66 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 1 catalyst2026-08-18: 2 catalysts2026-08-19: 3 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 1 catalyst2026-08-27: 1 catalyst2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 1 catalyst2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 2 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 2 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 1 catalyst2026-10-14: 1 catalyst2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 1 catalyst2026-10-20: 2 catalysts2026-10-21: 2 catalysts2026-10-22: 2 catalysts2026-10-23: 1 catalyst2026-10-24: 0 catalysts2026-10-25: 0 catalysts2026-10-26: 1 catalyst2026-10-27: 8 catalysts2026-10-28: 12 catalysts2026-10-29: 21 catalysts2026-10-30: 4 catalysts2026-10-31: 0 catalysts2026-11-01: 0 catalysts2026-11-02: 9 catalysts2026-11-03: 18 catalysts2026-11-04: 22 catalysts2026-11-05: 37 catalysts2026-11-06: 2 catalysts2026-11-07: 0 catalysts2026-11-08: 0 catalysts
view
agendamonth
sort
soonestlatesttypesponsoralpha
from 2026-03-04×clear all
type
  • 8k filing3,350
  • grant1,080
  • device adverse event1,000
  • earnings579
  • approval519
  • device 510k408
device pma
236
  • phase 2 completion172
  • drug shortage133
  • recall121
  • therapy area
    • Oncology148
    • Infectious Disease46
    • Cardiology37
    • Immunology35
    • Dermatology31
    • Pulmonology22
    • Women's Health19
    • Ophthalmology16
    • Pain15

    Week of Mar 2, 2026

    50
    ›Mar 5, 2026device recall163d agoPHILIPS MEDICAL SYSTEMS NEDERLAND B.V. device recall (Cls II)

    Vue Motion V12. Product Number: 1017979. — Reason: Potential that mis-ordered frames in Vue Motion during dynamic cine runs may cause images frames to display out of sequence. — Status: Ongoing

    full page →fda device recalls ↗
    ›Mar 5, 2026grant163d agoUNIVERSITY OF MICHIGAN AT ANN ARBOR — Reprogramming cells for repair of chronic wounds

    GM grant. $409,941. PI: Aaron Harvey Morris

    full page →nih reporter ↗
    ›Mar 5, 2026grant163d agoSANFORD RESEARCH NORTH — Identifying the Specific Reward Processes Underlying the Maintenance of Binge...

    MH grant. $442,750. PI: Lauren Marie Schaefer

    full page →nih reporter ↗
    ›Mar 5, 2026grant163d agoNORTHWESTERN UNIVERSITY AT CHICAGO — Contributions of Myeloid Peroxisomes to Inflammation in HeartNorthwestern University

    HL grant. $44,751. PI: Abhishek Vijay Thakkar

    full page →nih reporter ↗
    ›Mar 5, 2026grant163d agoUNIV OF NORTH CAROLINA CHAPEL HILL — Core C: Animal Model Core

    CA grant. $550,210. PI: Shawn Hingtgen

    full page →nih reporter ↗
    ›Mar 5, 2026grant163d agoUNIVERSITY OF TENNESSEE KNOXVILLE — Pioneering Mass Spectrometry-Based Footprinting to Reveal Human Membrane Prot...

    GM grant. $406,112. PI: Jie Sun

    full page →nih reporter ↗
    ›Mar 5, 2026grant163d agoJOHNS HOPKINS UNIVERSITY — Biophysical theory for condensate dynamics: advancing beyond minimal modelsJohns Hopkins University

    GM grant. $406,026. PI: Yaojun Zhang

    full page →nih reporter ↗
    ›Mar 5, 2026grant163d agoSTATE UNIVERSITY NEW YORK STONY BROOK — Deciphering the regulatory mechanisms of extracellular particle-mediated sign...

    GM grant. $432,569. PI: Simou Sun

    full page →nih reporter ↗
    ›Mar 5, 2026grant163d agoUNIVERSITY OF NOTRE DAME — Autonomous Hybrid Bioprinting of Hierarchical Perfusable Vascularized Liver T...

    EB grant. $662,737. PI: Yanliang Zhang

    full page →nih reporter ↗
    ›Mar 5, 2026grant163d agoUNIVERSITY OF HOUSTON — Epidemiology, etiology, and pathways to DLD: The role of late talking in ling...

    DC grant. $2,387,184. PI: JACK M FLETCHER

    full page →nih reporter ↗
    ›Mar 5, 2026grant163d agoMEDICAL UNIVERSITY OF SOUTH CAROLINA — Adapting Written Exposure Therapy for Adolescents with Posttraumatic Stress D...

    MH grant. $208,794. PI: Emily Lauren Tilstra-Ferrell

    full page →nih reporter ↗
    ›Mar 5, 2026grant163d agoKENNESAW STATE UNIVERSITY — Workflow Optimization for School-based Preventive Oral Health Services Delivery

    DE grant. $555,081. PI: Christina Scherrer

    full page →nih reporter ↗
    ›Mar 5, 2026grant163d agoBAYLOR COLLEGE OF MEDICINE — Ethics and Decision-Making in Translational Neurological Device ResearchBaylor College of Medicine

    MH grant. $445,816. PI: Jennifer Blumenthal-Barby

    full page →nih reporter ↗
    ›Mar 5, 2026grant163d agoUNIVERSITY OF WYOMING — Cell Fusion and Gene Expression in the C. elegans Epidermis

    GM grant. $123,687. PI: Owen Funk

    full page →nih reporter ↗
    ›Mar 5, 2026grant163d agoNEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC — Longitudinal Pet Imaging Of Antipsychotic Binding To The Dopamine-3 Receptor ...

    MH grant. $843,322. PI: Ragy Ramsis Girgis

    full page →nih reporter ↗
    ›Mar 5, 2026grant163d agoUNIVERSITY OF PENNSYLVANIA — Training Leaders to Improve Outcomes in Older Adults Using Advanced MethodsUniversity of Pennsylvania

    AG grant. $214,223. PI: Robert Edward Burke

    full page →nih reporter ↗
    ›Mar 5, 2026grant163d agoUNIVERSITY OF COLORADO — The Menses Study: Menstrual blood as a novel target-tissue biomatrix for chem...

    OD grant. $434,110. PI: Jenni Shearston

    full page →nih reporter ↗
    ›Mar 5, 2026grant163d agoNEW YORK UNIVERSITY — Neural circuit mechanisms of dynamic learning ratesNew York University

    MH grant. $710,563. PI: Christine M Constantinople

    full page →nih reporter ↗
    ›Mar 5, 2026grant163d agoUNIVERSITY OF CALIFORNIA LOS ANGELES — Mapping the Mechanome: A Systems-level Understanding of Mechanical Mediators ...University of California Los Angeles

    GM grant. $433,125. PI: Amy C Rowat

    full page →nih reporter ↗
    ›Mar 5, 2026grant163d agoBOSTON UNIVERSITY (CHARLES RIVER CAMPUS) — Advancing targeted delivery of intracellular protein therapeutics

    GM grant. $449,625. PI: Samagya Banskota

    full page →nih reporter ↗
    ›Mar 5, 2026grant163d agoUNIVERSITY OF IOWA — Role of Notch Pathway in the Pathogenesis of Chronic PancreatitisUniversity of Iowa

    DK grant. $655,482. PI: VIKAS DUDEJA

    full page →nih reporter ↗
    ›Mar 5, 2026grant163d agoICAHN SCHOOL OF MEDICINE AT MOUNT SINAI — Controlling epilepsy symptoms with precisely timed inhibition and circuit edi...

    NS grant. $75,880. PI: Christopher David Adam

    full page →nih reporter ↗
    ›Mar 5, 2026grant163d agoUT SOUTHWESTERN MEDICAL CENTER — The roles of Rett Syndrome protein MECP2 at gene regulatory elements

    MH grant. $641,828. PI: Hume Akahori Stroud

    full page →nih reporter ↗
    ›Mar 5, 2026grant163d agoRUTGERS BIOMEDICAL AND HEALTH SCIENCES — Loneliness and inflammatory markers as biopsychosocial pathways to AD/ADRD: A...

    AG grant. $121,239. PI: Mara Getz Sheftel

    full page →nih reporter ↗
    ›Mar 5, 2026grant163d agoCINCINNATI CHILDRENS HOSP MED CTR — Impact of Circadian Misalignment for Adolescents with ADHD: Observational and...

    MH grant. $820,196. PI: Stephen P Becker

    full page →nih reporter ↗
    ›Mar 5, 2026grant163d agoUNIVERSITY OF IOWA — Investigating single cell transcriptomics and epigenetic regulation to enable...University of Iowa

    MH grant. $779,797. PI: Rainbo Hultman

    full page →nih reporter ↗
    ›Mar 5, 2026grant163d agoHENRY M. JACKSON FDN FOR THE ADV MIL/MED — Neural Plasticity and Myelin Dynamics after Amputation

    NS grant. $555,265. PI: Emily Rose Petrus

    full page →nih reporter ↗
    ›Mar 5, 2026grant163d agoPUBLIC HEALTH FOUNDATION ENTERPRISES — PrEP Blueprint: Evaluating implementation of a PrEP Choice Blueprint on PrEP ...

    MH grant. $659,242. PI: Hyman Scott

    full page →nih reporter ↗
    ›Mar 5, 2026grant163d agoSTANFORD UNIVERSITY — The role of expected informativity on linguistic and memory encodingStanford University

    DC grant. $124,686. PI: Eleonora Judith Beier

    full page →nih reporter ↗
    ›Mar 5, 2026grant163d agoEMORY UNIVERSITY — A Foot in Each World: Bridging the Divide Between Clinical Research and the M...Emory University

    MH grant. $156,500. PI: Santiago Jose Arconada Alvarez

    full page →nih reporter ↗
    ›Mar 5, 2026grant163d agoBRIGHAM AND WOMEN'S HOSPITAL — Cellular Therapy for Sepsis and Lung InjuryBrigham and Women's Hospital

    GM grant. $445,983. PI: Mark A PERRELLA

    full page →nih reporter ↗
    ›Mar 5, 2026grant163d agoUNIVERSITY OF MICHIGAN AT ANN ARBOR — Mechanisms that regulate cellular responses to phosphate

    GM grant. $429,000. PI: Lauren Elizabeth Surface

    full page →nih reporter ↗
    ›Mar 5, 2026grant163d agoPENNSYLVANIA STATE UNIVERSITY, THE — Investigating brain-body allostasis via longitudinal in vivo imaging

    GM grant. $407,603. PI: Grayson Oren Sipe

    full page →nih reporter ↗
    ›Mar 5, 2026grant163d agoUNIVERSITY OF MARYLAND BALTIMORE — SGLT2 - Novel Molecular Mechanism of AQP4 Regulation

    NS grant. $602,065. PI: J. Marc Simard

    full page →nih reporter ↗
    ›Mar 6, 2026approval162d agoSKYRIZI (RISANKIZUMAB-RZAA) — FDA approvalrisankizumab

    Sponsor: ABBVIE INC. Form: INJECTABLE. Route: INTRAVENOUS

    full page →risankizumab →fda approvals ↗
    ›Mar 6, 2026approval162d agoSKYRIZI (RISANKIZUMAB-RZAA) — FDA approvalrisankizumab

    Sponsor: ABBVIE INC. Form: INJECTABLE. Route: INJECTION

    full page →risankizumab →fda approvals ↗
    ›Mar 6, 2026approval162d agoQUDEXY XR (TOPIRAMATE) — FDA approvalLP Pharmaceutical (Xiamen) Co Ltd

    Sponsor: UPSHER SMITH LABS. Form: CAPSULE, EXTENDED RELEASE. Route: ORAL

    full page →fda approvals ↗
    ›Mar 6, 2026approval162d agoPYLARIFY TRUVU (PIFLUFOLASTAT F-18) — FDA approval

    Sponsor: APHELION. Form: SOLUTION. Route: INTRAVENOUS

    full page →fda approvals ↗
    ›Mar 6, 2026approval162d agoSANDIMMUNE (CYCLOSPORINE) — FDA approvalRestasis

    Sponsor: NOVARTIS. Form: CAPSULE. Route: ORAL

    full page →Restasis →fda approvals ↗
    ›Mar 6, 2026approval162d agoQSYMIA (PHENTERMINE HYDROCHLORIDE) — FDA approval(phentermine hydrochloride + topiramate) ER

    Sponsor: VIVUS LLC. Form: CAPSULE, EXTENDED RELEASE. Route: ORAL

    full page →(phentermine hydrochloride + topiramate) ER →fda approvals ↗
    ›Mar 6, 2026approval162d agoTOPAMAX SPRINKLE (TOPIRAMATE) — FDA approvalJanssen Therapeutics

    Sponsor: JANSSEN PHARMS. Form: CAPSULE. Route: ORAL

    full page →fda approvals ↗
    ›Mar 6, 2026approval162d agoXELJANZ XR (TOFACITINIB CITRATE) — FDA approvaltofacitinib citrate ER

    Sponsor: PFIZER. Form: TABLET, EXTENDED RELEASE. Route: ORAL

    full page →tofacitinib citrate ER →fda approvals ↗
    ›Mar 6, 2026approval162d agoXELJANZ (TOFACITINIB CITRATE) — FDA approvalBiocon Pharma Ltd

    Sponsor: PF PRISM CV. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Mar 6, 2026approval162d agoVITAMIN K1 (PHYTONADIONE) — FDA approvalPHYTONADIONE

    Sponsor: HOSPIRA. Form: INJECTABLE. Route: INJECTION

    full page →PHYTONADIONE →fda approvals ↗
    ›Mar 6, 2026approval162d agoVITAMIN K1 (PHYTONADIONE) — FDA approvalPHYTONADIONE

    Sponsor: HOSPIRA. Form: INJECTABLE. Route: INJECTION

    full page →PHYTONADIONE →fda approvals ↗
    ›Mar 6, 2026approval162d agoTOPAMAX (TOPIRAMATE) — FDA approvalJanssen Therapeutics

    Sponsor: JANSSEN PHARMS. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Mar 6, 2026approval162d agoSIPONIMOD — FDA approvalSIPONIMOD

    Sponsor: AUROBINDO PHARMA LTD. Form: TABLET. Route: ORAL

    full page →SIPONIMOD →fda approvals ↗
    ›Mar 6, 2026approval162d agoCARBAMAZEPINE — FDA approvalcarbamazepine ER

    Sponsor: APOTEX. Form: TABLET. Route: ORAL

    full page →carbamazepine ER →fda approvals ↗
    ›Mar 6, 2026approval162d agoSOTYKTU (DEUCRAVACITINIB) — FDA approvalBristol-Myers Squibb Co

    Sponsor: BRISTOL. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Mar 6, 2026approval162d agoTROKENDI XR (TOPIRAMATE) — FDA approvalSUPERNUS PHARMACEUTICALS, INC.

    Sponsor: SUPERNUS PHARMS. Form: CAPSULE, EXTENDED RELEASE. Route: ORAL

    full page →fda approvals ↗
    ← prev
    page 3 of 149
    next →
    $SUPN48.27+2.38%
    $PFE26.79-0.04%
    $NVS150.88-0.55%
    $ABBV249.46-0.54%
    $ABBV249.46-0.54%